Despite affecting 77% of women by menopause, uterine fibroid research faces critical limitations due to inadequate animal models that fail to replicate human disease pathophysiology, genetic patterns, and tissue characteristics, forcing scientists to develop innovative three-dimensional cell culture alternatives for better treatment development.
Anilocus primarily works with mice and rats for preclinical research, covering standard laboratory strains and specialized models. While rodents handle most research needs, the team can accommodate alternative models when scientifically appropriate, focusing on whatever approach best serves specific research objectives and regulatory requirements.
CRISPR-Cas9 technology revolutionizes knockout mouse model creation by enabling precise gene editing with 95% efficiency. This advanced system allows researchers to generate specific genetic modifications in weeks rather than months, accelerating drug discovery and disease research with unprecedented accuracy and reproducibility.
This protocol shows researchers how to surgically implant cancer cells into the correct organ locations in mice or rats to create realistic tumor models. These orthotopic models help scientists test new cancer treatments by mimicking human disease progression, enabling better safety and effectiveness evaluation before clinical trials.
Bold ideas and breakthrough research. Expert analysis on the innovations and drug development for the most important people in the world: patients.
Use this form to send your questions to our research team about our preclinical contract research services.
We are here to help!
